Citadel Advisors
CLPT icon

Citadel Advisors’s ClearPoint Neuro CLPT Stock Holding History

Citadel Advisors’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.3M Buy
128,900
+70,400
+120% +$879K ﹤0.01% 6252
2026
Q1 		$532K Sell
58,500
-55,300
-49% -$698K ﹤0.01% 9149
2025
Q4 		$1.56M Buy
113,800
+13,900
+14% +$258K ﹤0.01% 6428
2025
Q3 		$2.18M Buy
99,900
+77,500
+346% +$913K ﹤0.01% 5910
2025
Q2 		$267K Sell
22,400
-29,900
-57% -$376K ﹤0.01% 10062
2025
Q1 		$622K Sell
52,300
-13,300
-20% -$207K ﹤0.01% 7997
2024
Q4 		$1.01M Buy
65,600
+37,600
+134% +$487K ﹤0.01% 6991
2024
Q3 		$314K Buy
28,000
+7,300
+35% +$69.9K ﹤0.01% 9241
2024
Q2 		$112K Sell
20,700
-1,900
-8% -$11K ﹤0.01% 10756
2024
Q1 		$154K Sell
22,600
-26,100
-54% -$182K ﹤0.01% 10733
2023
Q4 		$331K Sell
48,700
-11,000
-18% -$62.3K ﹤0.01% 8971
2023
Q3 		$299K Buy
59,700
+15,400
+35% +$91.6K ﹤0.01% 9179
2023
Q2 		$321K Buy
44,300
+19,100
+76% +$162K ﹤0.01% 8897
2023
Q1 		$213K Buy
25,200
+5,900
+31% +$51.7K ﹤0.01% 10080
2022
Q4 		$163K Sell
19,300
-39,000
-67% -$370K ﹤0.01% 10470
2022
Q3 		$604K Sell
58,300
-11,300
-16% -$149K ﹤0.01% 8049
2022
Q2 		$908K Buy
69,600
+13,900
+25% +$142K ﹤0.01% 7231
2022
Q1 		$580K Sell
55,700
-15,200
-21% -$138K ﹤0.01% 9039
2021
Q4 		$796K Sell
70,900
-21,900
-24% -$328K ﹤0.01% 8496
2021
Q3 		$1.65M Buy
92,800
+25,400
+38% +$476K ﹤0.01% 6852
2021
Q2 		$1.29M Buy
67,400
+57,900
+609% +$1.12M ﹤0.01% 7687
2021
Q1 		$201K Buy
+9,500
New +$203K ﹤0.01% 11687

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
CFM
Compass Financial Management Tampa, Florida $829M AUM

Citadel Advisors's CLPT Position: Q2 2026 in Review

Citadel Advisors opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 48,688 shares worth $869K. The stake represents ﹤0.01% of the portfolio and ranks #8560 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in CLPT as recently as Q4 2025.

Citadel Advisors first reported a position in CLPT in Q3 2019 and has held it in 20 quarters since. The position peaked at $1.88M in Q3 2025. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

  • Citadel Advisors held 48,688 shares of ClearPoint Neuro worth $869K as of Q2 2026.
  • ClearPoint Neuro was a new Citadel Advisors position in Q2 2026.
  • ClearPoint Neuro made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #8560 holding.
  • Citadel Advisors first reported a position in ClearPoint Neuro in Q3 2019 and has held it in 20 quarters since.
  • Citadel Advisors's ClearPoint Neuro position peaked at $1.88M in Q3 2025.
  • 129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.